Richard J. Ablin

Corporate Officer/Principal presso Tetragenex Pharmaceuticals, Inc.

Consumer Services

Health Technology

Posizioni attive di Richard J. Ablin

Società	Posizione	Inizio	Fine
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Corporate Officer/Principal	05/02/2010	-

Società	Posizione	Inizio	Fine
The State University of New York	Direttore/Membro del Consiglio	01/01/1989	01/01/1989
The State University of New York	Corporate Officer/Principal	01/01/1989	01/01/1989

State University of New York at Buffalo

Doctorate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	2
Director/Board Member	1
Doctorate Degree	1

Settori

Consumer Services	3
Health Technology	2

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	1
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Health Technology

Aziende private

Health Technology